Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Daniel Wendling »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Daniel W. Lee < Daniel Wendling < Daniel Wenning  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000584 (2019) Cécile Luxembourger [France] ; Adeline Ruyssen-Witrand [France] ; Chayma Ladhari [France] ; Cécile Rittore [France] ; Yannick Degboe [France] ; Jean-Francis Maillefert [France] ; Philippe Gaudin [France] ; Hubert Marotte [France] ; Daniel Wendling [France] ; Christian Jorgensen [France] ; Alain Cantagrel [France] ; Arnaud Constantin [France] ; Delphine Nigon [France] ; Isabelle Touitou [France] ; Jacques-Eric Gottenberg [France] ; Yves-Marie Pers [France]A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients.
000800 (2018) William Terreaux [France] ; Claire Masson [France] ; Jean-Paul Eschard [France] ; Thomas Bardin [France] ; Arnaud Constantin [France] ; Loïc Le Dantec [France] ; Christian Marcelli [France] ; Aleth Perdriger [France] ; Claire Scotto Di Fazano [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Jacques Morel [France] ; Jean-Hugues Salmon [France]Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE.
000846 (2018) Guillaume Moulis [France] ; Grégory Pugnet [France] ; Nathalie Costedoat-Chalumeau [France] ; Alexis Mathian [France] ; Gaëlle Leroux [France] ; Jonathan Boutémy [France] ; Olivier Espitia [France] ; Laurence Bouillet [France] ; Sabine Berthier [France] ; Jean-Baptiste Gaultier [France] ; Pierre-Yves Jeandel [France] ; Amadou Konaté [France] ; Arsène Mékinian [France] ; Elisabeth Solau-Gervais [France] ; Benjamin Terrier [France] ; Daniel Wendling [France] ; Fanny Andry [France] ; Camille Garnier [France] ; Pascal Cathébras [France] ; Laurent Arnaud [France] ; Aurore Palmaro [France] ; Patrice Cacoub [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Philippe Arlet [France] ; Maryse Lapeyre-Mestre [France] ; Laurent Sailler [France]Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.
000F82 (2015) Clémentine Fortunet [France] ; Yves-Marie Pers [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Elodie Constant [France] ; Hervé Devilliers [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Jean Francis Maillefert [France]Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
001039 (2015) Yves-Marie Pers [France] ; Marie Godfrin-Valnet ; Joseph Lambert ; Clémentine Fortunet ; Elodie Constant ; Thibault Mura ; Béatrice Pallot-Prades ; Christian Jorgensen ; Jean-Francis Maillefert ; Hubert Marotte ; Daniel Wendling ; Philippe GaudinResponse to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient.
001056 (2015) Hélène Bauer [France] ; Cécile Luxembourger ; Jacques-Eric Gottenberg ; Sophie Fournier ; Florence Abravanel ; Alain Cantagrel ; Emmanuel Chatelus ; Pascal Claudepierre ; Christophe Hudry ; Jacques Izopet ; Sylvie Fabre ; Guillaume Lefevre ; Laurent Marguerie ; Antoine Martin ; Laurent Messer ; Anna Molto ; Béatrice Pallot-Prades ; Yves-Marie Pers ; Anne-Marie Roque-Afonso ; Christian Roux ; Christelle Sordet ; Martin Soubrier ; Claire Veissier ; Daniel Wendling ; Jean-Marie Péron ; Jean SibiliaOutcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.
001128 (2015) Yves-Marie Pers [France] ; Roxane Schaub [France] ; Elodie Constant [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Clémentine Fortunet [France] ; Waafa Bourichi [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Jean-Francis Maillefert [France] ; Hubert Marotte [France]Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis.
001302 (2014) Yves-Marie Pers [France] ; Clémentine Fortunet ; Elodie Constant ; Joseph Lambert ; Marie Godfrin-Valnet ; Audrey De Jong ; Grégoire Mercier ; Béatrice Pallot Prades ; Daniel Wendling ; Philippe Gaudin ; Christian Jorgensen ; Hubert Marotte ; Jean-Francis MaillefertPredictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice.
001356 (2014) Claire Vidon [France] ; Marie Bossert [France] ; Anne Lohse-Walliser [France] ; Marie Godfrin-Valnet [France] ; Jean-Charles Balblanc [France] ; Daniel Wendling [France]Hair-cycle changes in two patients taking tocilizumab.
001458 (2013) Daniel Wendling ; Marie Godfrin-Valnet ; Clément PratiTreatment of relapsing polychondritis with tocilizumab.
001569 (2013) Daniel Wendling ; Sylvère Hugonnot ; Florent Montini ; Clément PratiInfluenza H1N1 infection in a patient with rheumatoid arthritis treated with tocilizumab.
001586 (2013) Daniel Wendling [France] ; Claire Vidon ; Marie Godfrin-Valnet ; Gilles Rival ; Xavier Guillot ; Clément PratiExacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis.
001727 (2012) Daniel Wendling ; Hélène Letho-Gyselinck ; Xavier Guillot ; Clément PratiPsoriasis onset with tocilizumab treatment for rheumatoid arthritis.
001752 (2012) Fernando Kemta Lekpa [France] ; Cécile Poulain ; Daniel Wendling ; Martin Soubrier ; Michel De Bandt ; Jean Marie Berthelot ; Philippe Gaudin ; Eric Toussirot ; Philippe Goupille ; Thao Pham ; Jérémie Sellam ; Rémy Bruckert ; Muriel Paul ; Valérie Farrenq ; Pascal ClaudepierreIs IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.
001875 (2011) Daniel Wendling ; Emmanuelle Dernis ; Clément Prati ; Eric Frisch ; Bernard DelboscOnset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?
001935 (2011) Daniel Wendling ; Clément PratiBiologic agents for treating ankylosing spondylitis: beyond TNFα antagonists.
001971 (2010) Thao Pham [France] ; Pascal Claudepierre ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel ; Laure Gossec ; Jacques-Eric Gottenberg ; Philippe Goupille ; Séverine Guillaume ; Eric Hachulla ; Charles Masson ; Jacques Morel ; Xavier Puéchal ; Alain Saraux ; Thierry Schaeverbeke ; Daniel Wendling ; Eric Bruckert ; Stanislas Pol ; Xavier Mariette ; Jean SibiliaTocilizumab: therapy and safety management.
001999 (2010) Daniel Wendling ; Marie Bossert ; Clément PratiShort-term effect of IL-6 inhibition in spondylarthritis.
001A18 (2010) Daniel WendlingInterleukin-6 as a therapeutic target in spondylarthritis: comment on the article by Tanaka et al.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Daniel Wendling" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Daniel Wendling" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Daniel Wendling
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021